Stock listing

BX Swiss:I5X Precigen, Inc. Aktie

Swiss listing (BX Swiss) of Precigen, Inc. · home listing NASDAQ:PGEN

Follow Precigen, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:PGEN

$4.21 USD -0.06 (-1.4%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PGEN

Past year +7.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.07 – $4.36 USDNov 20, 2026
Volume
6.07M sharesNov 20, 2026
Market cap
$1.51B USDAt the close on Nov 20, 2026 · price × 358.5M shares outstanding
52-week range
$3.04 – $8.98 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$36.71M USDMedian day 4.41M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Precigen, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PGEN · Home$4.21 USD-0.06 (-1.4%)6,067,718$4.155$4.36$4.07$4.27Close on Nov 20, 2026
Frankfurt:I5X€3.83 EUR+0.13 (+3.5%)—€3.70€3.83€3.70€3.70Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PGEN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.21-0.06-1.4%$4.155$4.36$4.076,067,718
$4.27-0.02-0.5%$4.29$4.525$4.254,269,444
$4.29-0.01-0.2%$4.29$4.35$4.194,372,678
$4.30-0.24-5.3%$4.44$4.45$4.263,837,027
$4.54-0.12-2.6%$4.66$4.71$4.513,770,948
$4.66-0.06-1.3%$4.70$4.909$4.595,317,767
$4.72+0.20+4.4%$4.59$4.80$4.504,609,730
$4.52-0.21-4.4%$4.61$4.71$4.406,030,841
$4.73+0.26+5.8%$4.54$4.96$4.318,812,275
$4.47+0.25+5.9%$4.32$4.48$4.039,231,224
$4.22-0.835-16.5%$4.71$4.74$3.9226,645,214
$5.055-0.195-3.7%$5.31$5.34$4.72510,481,064
$5.25+0.11+2.1%$5.335$5.38$5.069,717,817
$5.14-1.80-25.9%$5.36$5.48$4.90520,620,637
$6.94+0.30+4.5%$6.49$7.04$6.498,104,600
$6.64+0.56+9.2%$6.20$6.99$6.067,742,800
$6.08-0.07-1.1%$6.06$6.35$6.033,673,400
$6.15+0.11+1.8%$6.01$6.22$5.963,789,900
$6.04-0.15-2.4%$6.24$6.31$6.012,546,300
$6.19-0.20-3.1%$6.35$6.38$6.154,347,000
$6.39-0.21-3.2%$6.50$6.63$6.286,253,400
$6.60-0.23-3.4%$6.79$6.92$6.575,969,100
$6.83+0.17+2.6%$6.62$6.95$6.516,173,900
$6.66+0.27+4.2%$6.45$6.68$6.314,138,800
$6.39-0.81-11.3%$7.19$7.22$6.315,486,300
$7.20-0.16-2.2%$7.31$7.55$7.173,951,600
$7.36-0.12-1.6%$7.48$7.70$7.334,196,700
$7.48-0.18-2.3%$7.60$7.71$7.482,400,100
$7.66-0.15-1.9%$7.77$7.87$7.632,163,300
$7.81+0.21+2.8%$7.60$7.84$7.483,383,300
$7.60+0.06+0.8%$7.49$7.64$7.403,829,300
$7.54-0.01-0.1%$7.38$7.75$7.354,148,500
$7.55-0.19-2.5%$7.79$7.90$7.495,132,200
$7.74-0.80-9.4%$8.51$8.60$7.5510,244,400
$8.54+0.33+4.0%$8.30$8.55$8.186,361,900
$8.21-0.35-4.1%$8.50$8.64$8.194,612,700
$8.56+0.51+6.3%$8.13$8.98$8.0911,682,400
$8.05+0.24+3.1%$7.80$8.10$7.804,137,000
$7.81+0.06+0.8%$7.61$7.86$7.503,489,000
$7.75+0.05+0.6%$8.08$8.27$7.636,563,500
$7.70+0.26+3.5%$7.37$7.76$7.334,617,600
$7.44-0.45-5.7%$7.95$8.01$7.195,562,500
$7.89+0.19+2.5%$7.64$8.04$7.525,323,700
$7.70-0.08-1.0%$7.84$7.91$7.633,240,100
$7.78-0.09-1.1%$7.98$8.04$7.709,578,000
$7.87+0.43+5.8%$7.59$7.95$7.599,364,200
$7.44+0.44+6.3%$7.00$7.49$6.948,225,100
$7.00+0.15+2.2%$6.81$7.02$6.762,778,300
$6.850.000.0%$6.86$7.11$6.832,825,500
$6.85+0.17+2.5%$6.77$6.92$6.762,056,500
$6.68-0.12-1.8%$6.70$6.73$6.542,833,500
$6.80-0.07-1.0%$6.87$6.89$6.683,135,900
$6.87-0.23-3.2%$6.89$7.02$6.722,766,100
$7.10-0.04-0.6%$7.12$7.27$7.082,192,600
$7.14+0.13+1.9%$7.00$7.14$6.982,187,300
$7.01+0.15+2.2%$6.91$7.14$6.822,637,500
$6.86-0.07-1.0%$6.81$7.00$6.802,805,500
$6.93-0.02-0.3%$6.93$7.00$6.604,134,200
$6.95-0.24-3.3%$7.11$7.19$6.922,702,900
$7.19-0.23-3.1%$7.44$7.46$7.144,970,600
$7.42+0.14+1.9%$7.66$7.72$7.287,409,500
$7.28+0.11+1.5%$7.29$7.55$7.235,834,000
$7.17-0.03-0.4%$7.15$7.21$6.933,349,500
$7.20-0.24-3.2%$7.50$7.50$7.104,405,500
$7.44+0.28+3.9%$7.06$7.49$6.987,838,200
Ticker
BX Swiss:I5X
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
BX Swiss
Currency
CHF

What changed lately

Latest news

All Precigen, Inc. news

Precigen, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
19 in the last 12 months · 171 in all · newest Nov 10, 2026 · oldest 2019
Calls
15 calls with a replay · 15 with a transcript · latest Nov 4, 2026
Decks
34 decks · latest May 13, 2026

Where Precigen, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:PGEN · Home listingNASDAQUnited StatesUSD
gettex:I5XgettexGermanyEUR
Lang & Schwarz:A2PZG1Lang & SchwarzGermanyEUR
LS Exchange:A2PZG1LS ExchangeGermanyEUR
Tradegate:I5XTradegateGermanyEUR
BOATS:PGENBOATSUnited StatesUSD
Frankfurt:I5XFrankfurtGermanyEUR
BX Swiss:I5X · This pageBX SwissSwitzerlandCHF
Dusseldorf:I5XDusseldorfGermanyEUR
Hamburg:I5XHamburgGermanyEUR
Munich:I5XMunichGermanyEUR
Stuttgart:I5XStuttgartGermanyEUR

Valuation

P/E 61.9× against a median of 22.9×: 9th lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.56B USD
P/E
61.9×
EV/sales
9.9×
EV/EBITDA
40.9×
Price/book
18.0×
Gross margin
91.0%
Operating margin
21.4%
Net margin
15.6%
Debt to equity
1.1×
Beta vs S&P 500
1.46

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Precigen, Inc. · NASDAQ:PGENUS$1.51BUS$1.56B61.9×9.9×40.9×18.0×15.6%1.1×1.46
Fujian Cosunter Pharmaceutical Co., Ltd. Class A · SZSE:300436US$1.57BUS$1.47Bn/a22.8×n/a12.7×−48.9%0.2×n/a
Shanghai Shyndec Pharmaceutical Co., Ltd. Class A · SSE:600420US$1.56BUS$938.9M22.9×0.8×n/a0.8×5.7%0.0×n/a
ANI Pharmaceuticals, Inc. · NASDAQ:ANIPUS$1.56BUS$1.42B13.3×1.4×5.7×2.4×11.2%0.5×0.34
Zhejiang CONBA Pharmaceutical Co., Ltd. Class A · SSE:600572US$1.55BUS$1.42B22.6×1.4×n/a1.4×6.7%0.0×n/a
Tibet Cheezheng Tibetan Medicine Co., Ltd. Class A · SZSE:002287US$1.53BUS$1.15B16.2×3.4×n/a2.0×28.2%0.0×n/a
Yifan Pharmaceutical Co., Ltd. Class A · SZSE:002019US$1.52BUS$1.61B32.6×2.2×n/a1.1×6.3%0.2×n/a
Corona Remedies Limited · NSE:CORONAUS$1.49BUS$1.48B74.8×9.8×46.7×17.2×13.2%0.0×n/a
Sunshine Lake Pharma Co., Ltd. Class H · HKEX:6887US$1.48BUS$1.48B36.1×2.0×9.0×2.5×5.7%0.4×n/a
Zhejiang Medicine Co., Ltd. Class A · SSE:600216US$1.47BUS$975.3M15.5×0.8×n/a0.8×7.5%0.0×n/a
Yantai Dongcheng Biochemicals Co., Ltd. Class A · SZSE:002675US$1.47BUS$1.41B46.5×3.6×n/a2.2×8.0%0.1×n/a
Median of the othersUS$1.53BUS$1.42B22.9×2.1×9.0×2.1×7.1%0.1×0.34

Forecasts

2 strong buy · 1 buy · 1 hold · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
13.67 USD · Analysts' mean
EPS, year to Dec 2026
0.24 · 4 analysts
Revenue, year to Dec 2026
240.2M · 4 analysts

Team and board

Officers

OfficerRole
Helen SabzevariPresident and CEO
Harry ThomasianChief Financial Officer
Rutul R. ShahChief Operating Officer
Donald LehrChief Legal Officer
Steven M. HarasymInvestor Relations
Amy R. LankfordSVP, Global Head of Regulatory Affairs
Bryan T. ButmanSVP, Head of CMC
Douglas E. BroughSVP, Head of Research
Gaetano BonifacioSVP, Head of Development
Phil TennantChief Commercial Officer
Randal J. KirkExecutive Chairman

Board

DirectorRole
Randal J. KirkExecutive Chairman
Cesar L. AlvarezDirector
Fred HassanDirector
Helen SabzevariPresident and CEO
James S. TurleyDirector
Jeffrey B. KindlerDirector
Nancy H. AgeeDirector
Steven R. FrankDirector
Vinita D. GuptaDirector

Events

Calls

CallWhenStatus
Precigen (NASDAQ:PGEN) Q3 2026 Earnings CallWed, Nov 04, 2026 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q2 2026 Earnings CallTue, Aug 04, 2026 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q1 2026 Earnings CallWed, May 13, 2026 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q4 2025 Earnings CallWed, Mar 25, 2026 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q3 2025 Earnings CallThu, Nov 13, 2025 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q4 2024 Earnings CallWed, Mar 19, 2025 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q2 2024 Earnings CallWed, Aug 14, 2024 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q4 2023 Earnings CallTue, Mar 19, 2024 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q2 2023 Earnings CallWed, Aug 09, 2023 · 8:30 AM ETReplay
Precigen (NASDAQ:PGEN) Q4 2022 Earnings CallWed, May 10, 2023 · 8:00 AM ETReplay
All 15 calls
CallWhenStatus
Precigen (NASDAQ:PGEN) Q1 2023 Earnings CallWed, May 10, 2023 · 8:00 AM ETReplay
Precigen (NASDAQ:PGEN) Q3 2022 Earnings CallWed, Nov 09, 2022 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
Precigen (NASDAQ:PGEN) Q2 2021 Earnings CallMon, Aug 09, 2021 · 4:05 PM ETReplay
Precigen (NASDAQ:PGEN) Q4 2020 Earnings CallMon, Mar 01, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · After close−16.5%
Q2 2026Aug 4, 2026 · After close+5.5%
Q1 2026May 13, 2026 · After close+10.8%
Q4 2025Mar 9, 2026+5.7%
Q3 2025Nov 13, 2025 · After close+25.6%
Q2 2025Aug 12, 2025 · After close+6.1%
Q1 2025May 14, 2025 · After close+2.3%
Q4 2024Mar 19, 2025+7.8%
Q3 2024Nov 14, 2024 · After close−6.8%
Q2 2024Aug 14, 2024 · After close−4.5%
All 20 quarters
QuarterResultsShare move
Q1 2024May 14, 2024 · After close+5.1%
Q4 2023Mar 19, 2024 · After close0.0%
Q3 2023Nov 9, 2023 · After close−13.5%
Q2 2023Aug 9, 2023 · Before open+6.9%
Q1 2023May 10, 2023 · Before open−4.0%
Q4 2022Mar 6, 2023 · After close+17.4%
Q3 2022Nov 9, 2022 · After close+21.1%
Q2 2022Aug 8, 2022 · After close+12.7%
Q1 2022May 9, 2022 · After close+12.2%
Q4 2021Mar 1, 2022 · Before open−4.0%

Open Events

Decks

DeckKindSlidesDate
Q1 2026 Earnings PresentationEarnings21 slidesMay 13, 2026
Corporate Update (August 2025)Corporate update24 slidesAug 18, 2025
39th Annual J.P. Morgan Healthcare Conference (January 2021)Conference23 slidesJan 13, 2021
Q2 2020 Earnings PresentationEarnings13 slidesAug 10, 2020
Q1 2020 Earnings PresentationEarnings14 slidesMay 6, 2020
Q4 2019 Earnings PresentationEarnings12 slidesMar 2, 2020
Intrexon — 38th Annual J.P. Morgan Healthcare Conference (January 2020)Conference24 slidesJan 15, 2020
Intrexon — Corporate Update (November 2019)Corporate update14 slidesNov 12, 2019
Intrexon — Q2 2019 Earnings PresentationEarnings10 slidesAug 8, 2019
Intrexon — Corporate Update (May 2019)Corporate update26 slidesMay 9, 2019
All 34 decks
DeckKindSlidesDate
Intrexon — Corporate Update (May 2019)Corporate update17 slidesMay 9, 2019
Intrexon — Q4 2018 Earnings PresentationEarnings21 slidesFeb 28, 2019
Intrexon — Corporate Update (January 2019)Corporate update53 slidesJan 7, 2019
Intrexon — Corporate Update (December 2018)Corporate update15 slidesDec 26, 2018
Intrexon — Q3 2018 Earnings PresentationEarnings22 slidesNov 8, 2018
Intrexon — Corporate Update (August 2018)Corporate update20 slidesAug 9, 2018
Intrexon — Q1 2018 Earnings PresentationEarnings18 slidesMay 10, 2018
Intrexon — FY2017 Earnings PresentationEarnings24 slidesMar 1, 2018
Intrexon — J.P. Morgan Healthcare Conference 2018Conference24 slidesJan 10, 2018
Intrexon — Investor Presentation (January 2018)Investor deck21 slidesJan 8, 2018
Intrexon — Q3 2017 Earnings PresentationEarnings24 slidesNov 9, 2017
Intrexon — Q2 2017 Earnings PresentationEarnings37 slidesAug 9, 2017
Intrexon — Q1 2017 Earnings PresentationEarnings32 slidesMay 10, 2017
Intrexon — FY2016 Earnings PresentationEarnings27 slidesMar 1, 2017
Intrexon — JP Morgan Healthcare Conference 2017Conference23 slidesJan 11, 2017
Intrexon — Q3 2016 Earnings PresentationEarnings20 slidesNov 9, 2016
Intrexon — Corporate Update (May 2016)Corporate update9 slidesMay 4, 2016
Intrexon — 34th Annual J.P. Morgan Healthcare Conference (January 2016)Conference31 slidesJan 13, 2016
Intrexon — Investor Day (November 2015)Investor day131 slidesNov 12, 2015
Intrexon — Corporate Update (September 2015)Corporate update16 slidesSep 28, 2015
Intrexon — Investor Presentation (May 2015)Investor deck30 slidesMay 12, 2015
Intrexon — JP Morgan Healthcare Conference 2015Conference31 slidesJan 14, 2015
Intrexon — Investor Presentation (May 2014)Investor deck33 slidesMay 27, 2014
Intrexon — J.P. Morgan Healthcare Conference 2014Conference19 slidesJan 15, 2014

Open Decks

Financings

RaiseDate
Private placement of 8.00% Series A Convertible Perpetual Preferred Stock and warrants
Announced: US$79M · Warrants at US$0.75
Buyers: Patient Capital Management (led the private placement through affiliates); Bill Miller; Randal J. Kirk
Insiders: Randal J. Kirk, executive chairman of the board of directors, participated
Use of proceeds: Working capital and general corporate purposes
Dec 27, 2024

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue9.68M3.92M6.22M26.9M14.3M32.0M90.7M151.2M231.0M190.9M
Cost of revenue6.10M4.27M6.12M6.34M53.7M44.8M5.37M63.3M33.3M37.7M
Gross profit3.59M-342.0K106.0K20.6M-39.4M-12.8M26.6M97.3M168.2M129.3M
Research and development41.3M53.1M48.6M47.2M47.9M39.4M39.4M404.6M143.2M112.1M
Selling, general and administrative70.1M41.3M40.4M48.0M74.1M91.7M100.8M137.8M146.1M142.3M
Operating income-110.5M-135.0M-99.8M-75.7M-91.9M-86.3M-86.3M-505.6M-137.9M-125.2M
Depreciation and amortization3.20M4.53M6.67M10.8M13.8M17.5M24.9M33.1M31.1M24.6M
EBITDA-107.3M-130.5M-93.1M-65.0M-78.2M-68.8M-61.4M-472.5M-106.7M-100.6M
Interest expense3.87M6.00K468.0K6.77M18.8M18.4M18.2M8.53M611.0K861.0K
Income before tax-250.6M-128.0M-96.4M-80.0M-111.0M-104.5M-171.3M-395.9M-78.4M-194.2M
Income tax3.00K-1.79M-458.0K-189.0K-160.0K-82.0K-930.0K-15.4M2.07M-3.88M
Net income-250.6M-126.2M-95.9M28.3M-92.2M-170.5M-322.3M-509.3M-117.0M-186.6M
Earnings per share, basic-1.37-0.47-0.390.14-0.47-1.02-2.09-3.93-0.98-1.58
Earnings per share, diluted-1.37-0.47-0.390.14-0.47-1.02-2.09-3.93-0.98-1.58

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents30.2M29.5M7.58M4.86M36.4M51.8M65.8M96.9M68.1M62.6M
Short-term investments67.6M68.4M55.3M51.1M72.2M48.3M9.26M119.6M6.27M174.6M
Receivables3.92M926.0K902.0K978.0K1.34M16.5M20.6M21.2M19.8M21.6M
Inventory9.58M01287.0K326.0K11.4M16.1M21.4M20.5M21.1M
Current assets115.2M102.4M68.8M118.2M156.6M148.9M234.6M285.5M154.0M315.2M
Property, plant and equipment13.8M13.8M7.11M7.33M8.60M34.9M44.0M86.9M112.7M64.7M
Goodwill15.2M19.1M26.6M36.9M37.6M54.4M54.1M93.6M93.8M157.2M
Total assets155.5M145.3M151.0M216.0M359.9M314.6M455.8M716.2M846.9M949.1M
Accounts payable12.0M3.53M1.73M4.07M3.11M4.60M5.53M12.0M8.70M8.48M
Current liabilities37.3M21.5M23.0M78.6M34.6M42.1M122.9M61.6M80.2M94.6M
Long-term debt93.2M00179.9M171.5M186.3M211.2M7.54M7.56M
Total debt93.2M07.10M86.4M179.9M171.9M218.0M211.7M8.04M7.95M
Total liabilities134.6M78.5M32.5M89.7M252.5M247.4M384.1M337.5M300.3M379.8M
Shareholders' equity20.9M38.5M118.5M126.3M107.3M67.2M71.7M362.9M533.6M560.2M
Shares outstanding353.9M292.9M248.9M208.2M206.7M187.7M163.3M160.0M122.1M118.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-87.8M-68.2M-66.9M-65.0M-55.8M-77.0M-135.9M-124.2M-103.7M-49.0M
Capital spending-2.00M-8.58M-1.54M-4.92M-7.25M-7.53M-37.9M-41.6M-46.7M-31.6M
Free cash flow-89.8M-76.8M-68.5M-70.0M-63.0M-84.5M-173.8M-165.8M-150.4M-80.6M
Cash from investing-1.53M-20.7M-3.09M226.4M-74.5M27.8M86.9M-151.2M104.3M-28.4M
Cash from financing90.0M110.6M29.6M-155.3M121.2M32.7M8.14M309.8M4.28M12.1M
Dividends paid-7.73M-42.0M
Share buybacks-2.20M001.00K608.0K35.1M313.0K2.34M-518.0K-518.0K
Change in cash717.0K21.7M-40.7M5.25M-8.91M-16.2M-41.7M34.6M5.95M-66.2M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 4, 2026ResultsSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
4 · Change in ownershipSep 24, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
144 · Notice of proposed saleAug 26, 2026Other filingsSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 25, 2026Insider tradeSEC
144 · Notice of proposed saleAug 25, 2026Other filingsSEC
144 · Notice of proposed saleAug 25, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 7, 2026Big-stake noticeSEC
144 · Notice of proposed saleAug 6, 2026Other filingsSEC
10-Q · Quarterly reportAug 4, 2026Quarterly reportSEC
8-K · Current reportAug 4, 2026ResultsSEC
4 · Change in ownershipAug 3, 2026Insider tradeSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
4 · Change in ownershipJul 31, 2026Insider tradeSEC
144 · Notice of proposed saleJul 31, 2026Other filingsSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
144 · Notice of proposed saleJul 1, 2026Other filingsSEC
144 · Notice of proposed saleJun 29, 2026Other filingsSEC
144 · Notice of proposed saleJun 29, 2026Other filingsSEC
144 · Notice of proposed saleJun 29, 2026Other filingsSEC
8-K · Current reportJun 24, 2026Management or board changeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
8-K · Current reportMay 13, 2026ResultsSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
ARS · Annual report to shareholdersApr 30, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 30, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipMar 31, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 31, 2026Big-stake noticeSEC
144 · Notice of proposed saleMar 30, 2026Other filingsSEC
10-K · Annual reportMar 25, 2026Annual reportSEC
8-K · Current reportMar 25, 2026ResultsSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
UPLOAD · Letter from the SECMar 5, 2026Other filingsSEC
CORRESP · Letter to the SECFeb 23, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
UPLOAD · Letter from the SECFeb 10, 2026Other filingsSEC
CORRESP · Letter to the SECJan 29, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeJan 23, 2026Big-stake noticeSEC
UPLOAD · Letter from the SECDec 23, 2025Other filingsSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
144 · Notice of proposed saleDec 22, 2025Other filingsSEC
4 · Change in ownershipDec 16, 2025Insider tradeSEC
144 · Notice of proposed saleDec 12, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 21, 2025Big-stake noticeSEC
4 · Change in ownershipNov 21, 2025Insider tradeSEC
144 · Notice of proposed saleNov 20, 2025Other filingsSEC
144/A · Notice of proposed sale, amendedNov 20, 2025Other filingsSEC
144 · Notice of proposed saleNov 19, 2025Other filingsSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
4 · Change in ownershipOct 1, 2025Insider tradeSEC
4 · Change in ownershipSep 30, 2025Insider tradeSEC
144 · Notice of proposed saleSep 30, 2025Other filingsSEC
144 · Notice of proposed saleSep 30, 2025Other filingsSEC
4 · Change in ownershipSep 30, 2025Insider tradeSEC
4 · Change in ownershipSep 30, 2025Insider tradeSEC
144 · Notice of proposed saleSep 29, 2025Other filingsSEC
4 · Change in ownershipSep 26, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeSep 23, 2025Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveSep 22, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 19, 2025Big-stake noticeSEC
4 · Change in ownershipSep 19, 2025Insider tradeSEC
144 · Notice of proposed saleSep 19, 2025Other filingsSEC
144 · Notice of proposed saleSep 18, 2025Other filingsSEC
CORRESP · Letter to the SECSep 17, 2025Other filingsSEC
8-K · Current reportSep 17, 2025FinancingSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
8-K · Current reportSep 3, 2025Material contractSEC
4 · Change in ownershipAug 29, 2025Insider tradeSEC
UPLOAD · Letter from the SECAug 26, 2025Other filingsSEC
S-3 · Registration statementAug 19, 2025Offer documentSEC
8-K · Current reportAug 18, 2025Material contractSEC
8-K · Current reportAug 18, 2025Current reportSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
8-K · Current reportJun 30, 2025Management or board changeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
ARS · Annual report to shareholdersMay 16, 2025Annual reportSEC
DEFA14A · Additional proxy materialMay 16, 2025Meeting noticeSEC
DEF 14A · Proxy statementMay 16, 2025Meeting noticeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportMay 14, 2025ResultsSEC
PRE 14A · Preliminary proxy statementMay 6, 2025Meeting noticeSEC
10-K/A · Annual report, amendedApr 28, 2025Annual reportSEC
4 · Change in ownershipApr 18, 2025Insider tradeSEC
4 · Change in ownershipApr 18, 2025Insider tradeSEC
4 · Change in ownershipApr 18, 2025Insider tradeSEC
4 · Change in ownershipApr 18, 2025Insider tradeSEC
4 · Change in ownershipApr 18, 2025Insider tradeSEC
10-K · Annual reportMar 19, 2025Annual reportSEC
8-K · Current reportMar 19, 2025ResultsSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
4 · Change in ownershipFeb 3, 2025Insider tradeSEC
8-K · Current reportJan 16, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 30, 2024Big-stake noticeSEC
4 · Change in ownershipDec 30, 2024Insider tradeSEC
8-K · Current reportDec 30, 2024Material contractSEC
8-K · Current reportDec 26, 2024Material contractSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 14, 2024ResultsSEC
8-K · Current reportNov 7, 2024Current reportSEC
8-K · Current reportOct 10, 2024Current reportSEC
8-K · Current reportSep 20, 2024Management or board changeSEC
8-K · Current reportAug 30, 2024Management or board changeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportAug 14, 2024ResultsSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedAug 13, 2024Big-stake noticeSEC
8-K · Current reportAug 9, 2024Material contractSEC
424B5 · ProspectusAug 8, 2024Offer documentSEC
424B5 · ProspectusAug 6, 2024Offer documentSEC
8-K · Current reportAug 6, 2024ResultsSEC
4 · Change in ownershipJul 24, 2024Insider tradeSEC
3 · Initial statement of ownershipJul 24, 2024Insider tradeSEC
4 · Change in ownershipJul 9, 2024Insider tradeSEC
3 · Initial statement of ownershipJul 9, 2024Insider tradeSEC
8-K · Current reportJul 5, 2024Management or board changeSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC

This page holds 200 of 1,001 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Precigen, Inc.’s releases · as of Oct 30, 2026

Common shares
358,549,980
Fully diluted
358,549,980

Fully diluted

LineSharesAs of
Common shares358,549,980Oct 30, 2026

Share count over time

CountShares
Oct 30, 2026358,549,980

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Patient Capital Management, LLC18M5.0%US$154MSep 30, 2026
BlackRock17.3M4.8%US$148MSep 30, 2026
Vanguard12M3.4%US$103MSep 30, 2026
State Street10.7M3.0%US$91.8MSep 30, 2026
Tang Capital Management LLC6.42M1.8%US$54.9MSep 30, 2026
Geode Capital5.09M1.4%US$43.6MSep 30, 2026
Boxer Capital Management, LLC4.32M1.2%US$37MSep 30, 2026
Morgan Stanley4.13M1.2%US$35.4MSep 30, 2026
Diametric Capital, LP3.92M1.1%US$33.5MSep 30, 2026
Fidelity3.91M1.1%US$33.5MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Iridian Asset Management LLC3.06M0.85%US$26.2MSep 30, 2026
Occam Crest Management LP2.72M0.76%US$23.3MSep 30, 2026
First Trust2.62M0.73%US$22.5MSep 30, 2026
Nuveen2.42M0.67%US$20.7MSep 30, 2026
Arrowstreet Capital, Limited Partnership2.34M0.65%US$20MSep 30, 2026
Qube Research & Technologies Ltd2.21M0.62%US$18.9MSep 30, 2026
UBS1.91M0.53%US$16.4MSep 30, 2026
Point72 Asset Management, L.P.1.9M0.53%US$16.3MSep 30, 2026
Schwab1.81M0.50%US$15.5MSep 30, 2026
Northern Trust1.79M0.50%US$15.4MSep 30, 2026
Citadel1.55M0.43%US$13.3MSep 30, 2026
Bank of America1.49M0.41%US$12.7MSep 30, 2026
Goldman Sachs1.48M0.41%US$12.7MSep 30, 2026
Prudential Financial Inc1.43M0.40%US$12.2MSep 30, 2026
Woodline Partners LP1.4M0.39%US$12MSep 30, 2026
Barclays1.35M0.38%US$11.6MSep 30, 2026
Tidal Investments LLC1.13M0.32%US$9.7MSep 30, 2026
JPMorgan865K0.24%US$7.04MSep 30, 2026
Polen Capital Management LLC697K0.19%US$5.97MSep 30, 2026
Essex Investment Management Co LLC683K0.19%US$5.85MSep 30, 2026
Victory Capital683K0.19%US$5.85MSep 30, 2026
Wellington681K0.19%US$5.83MSep 30, 2026
Franklin Templeton681K0.19%US$3.44MSep 30, 2026
GMT Capital Corp669K0.19%US$5.73MSep 30, 2026
Jane Street659K0.18%US$5.64MSep 30, 2026
Renaissance Technologies640K0.18%US$5.47MSep 30, 2026
LexAurum Advisors, LLC634K0.18%US$5.42MSep 30, 2026
Trexquant Investment LP581K0.16%US$4.98MSep 30, 2026
Raymond James Financial Inc516K0.14%US$4.42MSep 30, 2026
Lansing Street Advisors499K0.14%US$4.27MSep 30, 2026
RBC485K0.14%US$4.15MSep 30, 2026
BNY484K0.13%US$4.14MSep 30, 2026
Informed Momentum Co LLC470K0.13%US$4.03MSep 30, 2026
Russell Investments Group, Ltd.460K0.13%US$3.94MSep 30, 2026
Swiss National Bank397K0.11%US$3.39MSep 30, 2026
Cetera Investment Advisers384K0.11%US$3.29MSep 30, 2026
Virtus Investment Advisers, LLC379K0.11%US$3.24MSep 30, 2026
KBC Group NV357K0.10%US$3.05MSep 30, 2026
Invesco339K0.09%US$2.91MSep 30, 2026
CIBC333K0.09%US$3.23MSep 30, 2026

This page holds 50 of 236 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Patient Opportunity Trust12.9M3.6%US$73.5MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF7.09M2.0%US$40.4MJun 30, 2026
Vanguard Total Stock Market Index Fund5.69M1.6%US$32.4MJun 30, 2026
iShares Russell 2000 ETF4.96M1.4%US$28.2MJun 30, 2026
Fidelity Small Cap Index Fund2.11M0.59%US$13.2MJul 31, 2026
Vanguard Extended Market Index Fund2.02M0.56%US$11.5MJun 30, 2026
iShares Russell 2000 Growth ETF1.78M0.50%US$10.2MJun 30, 2026
Fidelity Small Cap Growth Fund1.68M0.47%US$10.5MJul 31, 2026
First Trust Small Cap Growth AlphaDEX Fund1.54M0.43%US$9.65MJul 31, 2026
iShares Biotechnology ETF1.12M0.31%US$6.37MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Russell 2000 Index Fund926K0.26%US$4.02MMay 31, 2026
Fidelity Extended Market Index Fund915K0.26%US$3.97MMay 31, 2026
Fidelity Small Cap Growth K6 Fund871K0.24%US$5.46MJul 31, 2026
Schwab U.S. Small-Cap ETF839K0.23%US$3.64MMay 31, 2026
First Trust Small Cap Core AlphaDEX Fund765K0.21%US$4.8MJul 31, 2026
Putnam Small Cap Value Fund693K0.19%US$3.01MMay 31, 2026
iShares Micro-Cap ETF647K0.18%US$3.69MJun 30, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF547K0.15%US$3.12MJun 30, 2026
Vanguard Health Care Index Fund528K0.15%US$2.29MMay 31, 2026
Schwab Small-Cap Index Fund469K0.13%US$2.94MJul 31, 2026
Master Small Cap Index Series361K0.10%US$2.06MJun 30, 2026
Fidelity Total Market Index Fund326K0.09%US$1.41MMay 31, 2026
Virtus Biotech Etf305K0.09%US$1.91MJul 31, 2026
Vanguard U.S. Momentum Factor ETF292K0.08%US$1.27MMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF285K0.08%US$1.62MJun 30, 2026
Fidelity Series Total Market Index Fund269K0.08%US$1.17MMay 31, 2026
Nuveen Small Cap Blend Index Fund256K0.07%US$1.6MJul 31, 2026
Putnam VT Small Cap Value Fund245K0.07%US$1.4MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account242K0.07%US$1.38MJun 30, 2026
Direxion Daily S&P Biotech Bull 3X Shares241K0.07%US$1.51MJul 31, 2026
Fidelity Nasdaq Composite Index Fund220K0.06%US$955KMay 31, 2026
EQ/2000 Managed Volatility Portfolio210K0.06%US$1.2MJun 30, 2026
Nuveen Equity Index Fund189K0.05%US$1.18MJul 31, 2026
1290 Essex Small Cap Growth Fund182K0.05%US$1.14MJul 31, 2026
Fidelity Small Cap Growth Index Fund181K0.05%US$1.03MJun 30, 2026
Vanguard Russell 2000 Growth Index Fund159K0.04%US$690KMay 31, 2026
Victory Small Cap Stock Fund145K0.04%US$906KJul 31, 2026
Inspire Small/Mid Cap ETF142K0.04%US$616KMay 31, 2026
EQ/Small Company Index Portfolio140K0.04%US$796KJun 30, 2026
First Trust Multi Cap Growth AlphaDEX Fund139K0.04%US$874KJul 31, 2026
LVIP State Street Small-Cap Index Fund137K0.04%US$783KJun 30, 2026
Fidelity Nasdaq Composite Index ETF127K0.04%US$550KMay 31, 2026
Schwab U.S. Broad Market ETF108K0.03%US$469KMay 31, 2026
Schwab Total Stock Market Index Fund108K0.03%US$675KJul 31, 2026
Small Cap Index Fund97,9790.03%US$558KJun 30, 2026
Fidelity ZERO Total Market Index Fund96,1580.03%US$603KJul 31, 2026
Fidelity MSCI Health Care Index ETF92,5000.03%US$580KJul 31, 2026
Global X Russell 2000 ETF92,2220.03%US$578KJul 31, 2026
Vanguard Balanced Index Fund87,5890.02%US$499KJun 30, 2026
Vanguard Institutional Total Stock Market Index Fund85,3250.02%US$486KJun 30, 2026

This page holds 50 of 145 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Kindler Jeffrey B
Director
Sale185,000USD 7.44US$1.38MAug 26, 2026
Tennant Phil
Officer: Chief Commercial Officer
Sale79,166USD 7.50US$594KAug 25, 2026
Shah Rutul R
Officer: Chief Operating Officer
Sale15,342USD 7.50US$115KAug 25, 2026
Shah Rutul R
Officer: Chief Operating Officer
Sale34,658USD 7.50US$260KAug 21, 2026
Agee Nancy H
Director
Buy3,411USD 7.23US$24,662Aug 21, 2026
Shah Rutul R
Officer: Chief Operating Officer
Sale32,739USD 6.86US$225KAug 6, 2026
Shah Rutul R
Officer: Chief Operating Officer
Sale33,772USD 6.50US$220KAug 3, 2026
Thomasian Harry Jr.
Officer: Chief Financial Officer
Sale100,000USD 6.06US$606KJul 31, 2026
Thomasian Harry Jr.
Officer: Chief Financial Officer
Sale171,429USD 5.53US$948KJul 1, 2026
Sabzevari Helen
Officer: President and CEO
Sale346,836USD 5.89US$2.04MJun 29, 2026
All 17 trades
TradeTradeSharesPriceValueDate
Shah Rutul R
Officer: Chief Operating Officer
Sale42,924USD 5.85US$251KJun 29, 2026
Thomasian Harry Jr.
Officer: Chief Financial Officer
Sale28,571USD 5.78US$165KJun 29, 2026
Sabzevari Helen
Officer: President and CEO
Sale119,250USD 4.36US$520KMay 28, 2026
Lehr Donald P.
Officer: Chief Legal Officer
Sale29,131USD 4.36US$127KMay 28, 2026
Shah Rutul R
Officer: Chief Operating Officer
Sale42,703USD 4.36US$186KMay 28, 2026
Tennant Phil
Officer: Chief Commercial Officer
Sale30,272USD 4.36US$132KMay 28, 2026
Thomasian Harry Jr.
Officer: Chief Financial Officer
Sale41,884USD 4.36US$183KMay 28, 2026

Big stakes

StakeStakeSharesDateFiling
Patient Capital Management, LLC10.20%36MDec 31, 2025Schedule 13G
William H. Miller III Living Trust dated April 17, 20179.20%34.1MJun 26, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Fred Hassan
Other companies: Recursion Pharmaceuticals, Inc. (Director · Since Oct 31, 2026); EyePoint, Inc. (Director · Since at least Sep 3, 2024); Cocrystal Pharma, Inc. (Director · Since at least Apr 20, 2023); BridgeBio Pharma, Inc. (Director · Since at least Aug 17, 2021); Prometheus Biosciences Inc (Director · May 14, 2021 – Jun 16, 2023 · Past); Time Warner Inc (Director · Jun 1, 2016 – Jun 14, 2018 · Past); Amgen Inc. (Director · Jul 28, 2015 – May 5, 2020 · Past)
Director · Since at least Jun 30, 2016
Nancy Howell Agee
Other companies: Atlantic Union Bankshares Corporation (Director · Since at least Apr 1, 2024); RGC Resources Inc. (Director · Since at least Jan 3, 2006); American National Bankshares Inc (Director · Apr 1, 2019 – Apr 1, 2024 · Past); Healthcare Realty Trust Incorporated (Director · Feb 17, 2016 – May 20, 2025 · Past); HomeTown Bankshares Corporation (Director · May 1, 2012 – Mar 9, 2017 · Past)
Director · Since at least Jul 5, 2024
Dean Mitchell
Other companies: Praxis Precision Medicines, Inc. (Chairman of the Board · Since at least Oct 15, 2020); Theravance Biopharma, Inc. (Director · Since at least Apr 30, 2019); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); ImmunoGen Inc (Director · Mar 31, 2019 – Feb 12, 2024 · Past)
Director · Mar 8, 2020 – Mar 14, 2024 · Past
Andrew J Last
Other companies: Insight Molecular Diagnostics Inc. (Director · Since at least Dec 30, 2015); Bio-Rad Laboratories, Inc. (EVP, Chief Operating Officer · Apr 22, 2019 – Sep 6, 2024 · Past); Affymetrix Inc (EVP, Chief Operating Officer · Feb 24, 2010 – Mar 31, 2016 · Past)
Chief Operating Officer · Aug 29, 2016 – Nov 13, 2017 · Past
James S. Turley
Other companies: Northrop Grumman Corporation (Director · Since at least Feb 19, 2015); Emerson Electric Company (Director · Since at least Jul 10, 2013); Citigroup, Inc. (Director · Since at least Jul 4, 2013)
Director · Since at least Apr 16, 2014
Jeffrey Kindler
Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jan 8, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Jun 10, 2024); Perrigo Company plc (Director · May 14, 2024 – May 14, 2025 · Past)
Director · Since at least Dec 28, 2023
Nir Nimrodi
Other companies: Evogene Ltd. (Chairperson of the Board · Since at least Mar 18, 2026); Odysight.ai Inc. (Director · Since at least Feb 10, 2025)
Chief Business Officer · Mar 17, 2014 – Jan 4, 2019 · Past
Olivier R. Jarry
Other companies: OS Therapies Incorporated (Chief Executive Officer · Since at least Oct 28, 2024); DarioHealth Corp. (See Remarks · Aug 30, 2018 – Jan 28, 2020 · Past)
SVP--Consumer Sector · Jun 11, 2015 – Jun 11, 2015 · Past
Randal J. Kirk
Other companies: Alaunos Therapeutics, Inc. (Director · Dec 30, 2011 – Oct 5, 2018 · Past); Halozyme Therapeutics, Inc. (Director · Nov 14, 2011 – Jul 24, 2017 · Past)
Executive Chairman · Since at least Aug 7, 2013
Robert B Shapiro
Other companies: NYSE Euronext Inc (Director · Apr 3, 2007 – Apr 27, 2007 · Past); Dyadic International, Inc. (Director · Feb 10, 2006 – Jan 2, 2007 · Past)
Director · Aug 7, 2013 – Mar 9, 2023 · Past
All 42 people
PersonSeat
Samuel Broder
Other companies: Orion Biotech Opportunities Corp (Director · May 12, 2021 – May 17, 2023 · Past); Sensei Biotherapeutics, Inc. (Director · Feb 3, 2021 – Jul 10, 2023 · Past)
SVP, Head of Health Sector · Aug 7, 2013 – Jul 21, 2015 · Past
Suma Krishnan
Other companies: Krystal Biotech, Inc. (President, Research & Development · Since at least Sep 19, 2017); New River Pharmaceuticals Inc (Vice President, Product Dev. · Mar 29, 2005 – Jan 25, 2007 · Past)
SVP--Product Development · Aug 7, 2013 – Jan 28, 2016 · Past
Thomas Bostick
Other companies: CSX Corporation (Director · Since at least Oct 7, 2020); Perma-Fix Environmental Services, Inc. (Director · Since at least Aug 10, 2020)
Chief Operating Officer · Nov 27, 2017 – Jan 4, 2020 · Past
Cesar L. Alvarez
Other companies: Watsco, Inc. (Director · Since at least Dec 31, 2021)
Director · Since at least Mar 3, 2021
Helen Sabzevari
Other companies: Kinnate Biopharma Inc (Director · Jun 24, 2021 – Apr 3, 2024 · Past)
President and CEO · Since at least Nov 27, 2017
Jack A Bobo
Other companies: AquaBounty Technologies, Inc. (Director · Dec 30, 2016 – Dec 30, 2016 · Past)
SVP, Chief Communications Off. · Jul 20, 2015 – Jul 20, 2015 · Past
Kelly Huang
Other companies: Vyome Holdings, Inc. (Pres & Chief Executive Officer, Director · Sep 8, 2017 – Jan 2, 2019 · Past)
SVP-Consumer Sector · Mar 17, 2014 – May 9, 2014 · Past
Krish Krishnan
Other companies: Krystal Biotech, Inc. (Chairman & CEO · Since at least Sep 19, 2017)
Chief Operating Officer · Aug 7, 2013 – Jan 28, 2016 · Past
Rick L Sterling
Other companies: AquaBounty Technologies, Inc. (Director · Mar 10, 2021 – Jun 14, 2023 · Past)
Chief Financial Officer · Dec 15, 2020 – Jan 4, 2021 · Past
Steven R. Frank
Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least May 2, 2025)
Director · Since at least Aug 7, 2013
Amy R. LankfordSVP, Global Head of Regulatory Affairs · Since at least Nov 5, 2026
Bryan T. ButmanSVP, Head of CMC · Since at least Nov 5, 2026
Corey HuckSVP, Food Sector · Oct 12, 2015 – Oct 12, 2015 · Past
D Bradford OsborneVP, Finance and Accounting · Apr 2, 2021 – Apr 21, 2021 · Past
Donald LehrChief Legal Officer · Since at least Aug 7, 2013
Douglas E. BroughSVP, Head of Research · Since at least Nov 5, 2026
Ena Chan CratsenburgSVP, Consumer Sector · Jan 7, 2016 – Jan 7, 2016 · Past
Gaetano BonifacioSVP, Head of Development · Since at least Jan 20, 2026
Harry ThomasianChief Financial Officer · Since at least Sep 24, 2026
Harry Thomasian JrChief Financial Officer · Since at least Oct 18, 2021
James Vincent LambertEx. Dir. Fin., PGEN Ther. Inc. · Jun 10, 2021 – Jun 10, 2021 · Past
Jeffrey Thomas PerezSVP, IP Affairs · Dec 15, 2020 – Aug 9, 2024 · Past
Joel D LiffmanSVP, Finance · Jul 20, 2015 – Jan 4, 2019 · Past
Joseph L VaillancourtSVP, Environment Sector · Oct 19, 2015 – Oct 19, 2015 · Past
Nick MacrisVP--Environmental Sector · Aug 7, 2013 – Aug 7, 2013 · Past
Phil TennantChief Commercial Officer · Since at least Jul 22, 2024
Robert F Walsh IIISVP, Energy & Fine Chem. · Aug 7, 2013 – Jun 30, 2019 · Past
Rutul R. ShahChief Operating Officer · Since at least Jan 13, 2025
Steven M. HarasymInvestor Relations · Since at least Nov 4, 2026
Thomas R KasserSVP--Food Sector · Aug 7, 2013 – May 9, 2014 · Past
Trading S A AresDirector · May 24, 2021 – May 24, 2021 · Past
Vinita D. GuptaDirector · Since at least Apr 25, 2017

Open People

Log in to ask 6ix AI your own questions about Precigen, Inc.